Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys. Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med. Evaluation in humans of a new, inactivated vaccine for Venezuelan equine encephalitis virus C J Infect Dis.
A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. Cultivation of the lansing strain of poliomyelitis virus in cultures of various human embryonic tissues.
Preparation of poliomyelitis virus for production of vaccine for the field trial. Can J Public Health. Uber die Immunisierung gegen Wutkranheit.
Z Hyg Infectionskrankh. The protective effect of vaccination against epidemic influenza B. J Am Med Assoc. Consumer acceptance of irradiated meat and poultry in the United States. J Food Prot. Estimation of residual free formaldehyde in biological products. Return of inactivated whole-virus vaccine for superior efficacy. The safety profile of varicella vaccine: a year review. Inactivation of poliovirus by formaldehyde: theoretical and practical aspects. Bull World Health Organ.
Inactivation of poliovirus by formaldehyde; analysis of inactivation curves. Inactivation of poliomyelitis virus by formaldehyde. Effect of viral membrane fusion activity on antibody induction by influenza H5N1 whole inactivated virus vaccine.
Bull Hist Med. Influenza surveillance. Diphtheria toxoid as an immunising agent. Br J Exp Pathol. J Clin Invest. Measles: old vaccines, new vaccines. Curr Top Microbiol Immunol. Live attenuated and inactivated influenza vaccine in school-age children.
Am J Dis Child. Aluminum compounds as vaccine adjuvants. Adv Drug Deliv Rev. The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription. Ross River virus transmission, infection, and disease: a cross-disciplinary review. Clin Microbiol Rev. Preparation and sterilization of blood plasma. Am J Clin Pathol.
Betapropiolactone in sterilization of vaccines, tissue grafts, and plasma. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med. Is it time for a new yellow fever vaccine? The global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox.
Flaviviruses and flavivirus vaccines. Reactions of beta-propiolactone, beta-butyrolactone and gamma-butyrolactone with nucleic acids. Paralytic disease associated with oral polio vaccines.
Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine. Regulatory, biosafety and safety challenges for novel cells as substrates for human vaccines. Environmental carcinogenesis in man and animals. Ann NY Acad Sci. Inactivated rotavirus vaccines: a priority for accelerated vaccine development. Immunogenicity of a thermally inactivated rotavirus vaccine in mice. Hum Vaccin. Vaccine-associated paralytic polio in India.
Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection. Pediatr Infect Dis J. An epidemiologic study of altered clinical reactivity to respiratory syncytial RS virus infection in children previously vaccinated with an inactivated RS virus vaccine.
Am J Epidemiol. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.
Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus. Rabies virus inactivation by binary ethylenimine: new method for inactivated vaccine production. J Clin Microbiol. Beta-propiolactone and aziridine: their applications in organic synthesis and viral inactivation.
Chim Oggi. Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older. Safety and immunogenicity of a novel human Enterovirus 71 EV71 vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial.
Adverse event reports following yellow fever vaccination. Use of hydrogen peroxide as a biocide: new consideration of its mechanisms of biocidal action.
J Antimicrob Chemother. Vaccination of immunocompromised patients. Clin Microbiol Infect. Investigations of the use of beta-propiolactone in virus inactivation. Studies of the inactivation of poliomyelitis virus by formaldehyde. In vitro inactivation of the rabies virus by ascorbic acid. Int J Infect Dis.
Experimental study of the role of inactivated vaccine in two-step vaccination against smallpox. Comparison of the immunological responses and efficacy of gamma-irradiated V vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB. Evaluation of formalin inactivated V virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus.
Immunogenicity and protective efficacy of a psoralen-inactivated dengue-1 virus vaccine candidate in Aotus nancymaae monkeys. An overview of the evolution of enterovirus 71 and its clinical and public health significance. Safety testing of poliomyelitis vaccine. Virus inactivation: lessons from the past. Identification of formaldehyde-induced modifications in proteins: reactions with insulin. Bioconjug Chem. Identification of formaldehyde-induced modifications in proteins: reactions with model peptides.
J Biol Chem. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers. A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines. An inactivated cell-culture vaccine against yellow fever.
Feasibility study to develop a common in vitro D antigen assay for inactivated poliomyelitis vaccines. Pharmeuropa Bio. Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity. The cutter incident. Relationship of poliomyelitis to cutter vaccine. Am J Hyg. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, to the pediatric experience.
The cutter incident, 50 years later. Noninfectious rotavirus strain RRV induces an immune response in mice which protects against rotavirus challenge.
Reaction of poliovirus and formaldehyde in magnesium chloride solution to enhance potency of killed-virus vaccine. J Med Virol. Intussusception and rotavirus vaccination: a review of the available evidence. A new antirabies vaccine for human use; clinical and laboratory results using rabies vaccine made from embryonated duck eggs. J Lab Clin Med.
Inactivation of DNA by beta-propiolactone. In: Pharmacopoeia E ed European Pharmacopoeia 7. Would an in vitro ELISA test be a suitable alternative potency method to the in vivo immunogenicity assay commonly used in the context of international hepatitis A vaccines batch release?
Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles. New findings in live, attenuated hepatitis A vaccine development. Propagation of human hepatitis A virus in cell culture in vitro.
An inactivated hepatitis A viral vaccine of cell culture origin. An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model. Toxin inactivation and antigen stabilization: two different uses of formaldehyde. Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine.
Immunity to aerosol challenge in guinea pigs immunized with gamma-irradiated Venezuelan equine encephalitis vaccines. Appl Microbiol. Gamma-irradiated Venezuelan equine encephalitis vaccines. Advances in vaccination against tick-borne encephalitis. Immunogenicity and protective efficacy in mice and hamsters of a beta-propiolactone inactivated whole virus SARS-CoV vaccine.
Viral Immunol. The reaction of beta-propiolactone with guanosine, deoxyguanylic acid and RNA. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.
Studies in human subjects on active immunization against poliomyelitis. A preliminary report of experiments in progress. Vaccination against paralytic poliomyelitis performance and prospects. Ann Intern Med. A review of theoretical, experimental, and practical considerations in the use of formaldehyde for the inactivation of poliovirus. Formaldehyde treatment and safety testing of experimental poliomyelitis vaccines.
Influenza vaccines: the good, the bad, and the eggs. Adv Virus Res. The isolation and characterization of 3- 2-carboxyethyl cytosine following in vitro reaction of beta-propiolactone with calf thymus DNA.
Superintendent Government Printing, Calcutta. Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands. In: Lippincott ed Disinfection and sterilization, Philadelphia Smorodintsev AA, Ilyenko VI Results of laboratory and epidemiological study of vaccination against tick-borne encephalitis. Advances in the development of inactivated virus vaccines. Recent Pat Antiinfect Drug Discov.
Aplhavirus Encephalitides. In: Dembek ZF, editor. Medical aspects of biological warfare. Results of immunization by means of active virus of human influenza. Development of Vero cell-derived inactivated Japanese encephalitis vaccine. IgE and IgG antibodies to beta-propiolactone and human serum albumin associated with urticarial reactions to rabies vaccine. Hydroperoxide-induced DNA damage and mutations. Mutat Res. Investigation of the detoxification mechanism of formaldehyde-treated tetanus toxin.
Reactions of beta-propiolactone with nucleobase analogues, nucleosides, and peptides: implications for the inactivation of viruses. ICH guidance for industry Q5A. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. Potency testing of killed polio vaccine in rats. And you keep coming back to personal attacks on me that have absolutely no relevance to reality.
The two GOPers also claimed that Fauci was aware in January that NIAID worked with the non-profit EcoHealth Alliance to design a policy that would sidestep a gain-of-function moratorium and allow it to complete dangerous experiments on novel bat coronaviruses. Comer and Jordan further contend that Fauci also knew in January that EcoHealth was not in compliance with the terms of its grant that funded the Chinese lab.
January 11, pm Updated January 11, pm. An email from Dr. May also include abnormal ranges. Interpretive Data Background information for test. May include disease information, patient result explanation, recommendations, details of testing, associated diseases, explanation of possible patient results. Compliance Category. Note Additional information related to the test.
CPT codes are provided only as guidance to assist clients with billing. CPT coding is the sole responsibility of the billing party. Click here for your pricing. Components Components of test. Advances and future challenges in adenoviral vector pharmacology and targeting. Curr Gene Ther 11 — Lachmann R. Herpes simplex virus-based vectors. Int J Exp Pathol 85 — Detection of multiple strains of latent herpes simplex virus type 1 within individual human hosts.
J Virol 52 — Biosafety of gene therapy vectors derived from herpes simplex virus type 1. Thermal inactivation of adenovirus type 5. J Virol Methods — Marshall E. Gene therapy death prompts review of adenovirus vector. Science — Ubiquitous human adeno-associated virus type 2 autonomously replicates in differentiating keratinocytes of a normal skin model.
Virology — Mingozzi F, High KA. Immune responses to AAV in clinical trials. Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity. Development of a self-inactivating lentivirus vector. Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation.
Mol Ther 11 — NIH guidelines for research involving recombinant or synthetic nucleic acid molecules. Integration frequency and intermolecular recombination of rAAV vectors in non-human primate skeletal muscle and liver.
Mol Ther 20 — Prolonged adherence of human immunodeficiency virus-derived vector particles to hematopoietic target cells leads to secondary transduction in vitro and in vivo. J Virol 81 — Virucidal effects of rodent cage-cleaning practices on the viability of adenovirus vectors.
Contemp Top Lab Anim Sci 41 — Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 80 — Assessment of hazard risk associated with the intravenous use of viral vectors in rodents. Comp Med 62 — Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity. Biosafety features of lentiviral vectors. Hum Gene Ther 24 — An inventory of shedding data from clinical gene therapy trials.
J Gene Med 9 — Spaete RR, Frenkel N. The herpes simplex virus amplicon: analyses of cis -acting replication functions. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease.
Nat Med 16 — Takara Bio. Fourth generation lentiviral packaging systems. Adenovirus E1A proteins induce apoptosis by both pdependent and pindependent mechanisms. Oncogene 11 — Biosafety considerations for research with lentiviral vectors. Valtierra HN. Stability of viral pathogens in the laboratory environment.
Appl Biosaf 13 Gene Ther 4 — DNA amplification of adeno-associated virus as a response to cellular genotoxic stress.
0コメント